《大行報告》瑞銀一舉升百威亞太(01876.HK)評級至「買入」 目標價上調至24.2元
瑞銀髮表研究報告指,百威亞太(01876.HK)第三季收入及EBITDA均按年增長3%,符合該行及市場預期,稅後淨利潤則勝預期,主要由於稅率較預期低。
期內中國內地市場銷量受疫情影響而有所下降,但產品平均售價仍錄得中單位數升幅。管理層宣佈從11月起中國核心+(Core+)細分市場的產品價格將上調3%至10%,以抵銷 明年的成本壓力;南韓市場市場份額持續提升,當中家庭消費貢獻擴大。
該行認爲,百威亞太的的估值下調已反映出市場對疫情及成本上升的擔憂,將2021至2023年每股盈利預測分別上調3%、5%及3%,並將評級由「沽售」一舉調升至「買入」,根據最新預測,將目標價由22.86元升至24.2元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.